Victory Capital Management’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-15,287
Closed -$22K 2835
2022
Q2
$22K Sell
15,287
-3,556
-19% -$2.61K ﹤0.01% 2611
2022
Q1
$12K Buy
18,843
+8,263
+78% +$13.5K ﹤0.01% 2675
2021
Q4
$26K Sell
10,580
-156
-1% -$613 ﹤0.01% 2684
2021
Q3
$55K Sell
10,736
-352
-3% -$2.14K ﹤0.01% 2680
2021
Q2
$92K Sell
11,088
-488
-4% -$4.11K ﹤0.01% 2610
2021
Q1
$101K Sell
11,576
-2,656,401
-100% -$27.5M ﹤0.01% 2605
2020
Q4
$29M Sell
2,667,977
-97,315
-4% -$1.2M 0.03% 725
2020
Q3
$33M Buy
2,765,292
+469,182
+20% +$6.28M 0.04% 600
2020
Q2
$36.9M Sell
2,296,110
-2,060,058
-47% -$36M 0.05% 534
2020
Q1
$67.6M Buy
4,356,168
+1,709,500
+65% +$36.7M 0.06% 474
2019
Q4
$65.1M Buy
2,646,668
+470,980
+22% +$6.99M 0.08% 372
2019
Q3
$22.4M Buy
2,175,688
+494,858
+29% +$6.24M 0.03% 755
2019
Q2
$21.1M Buy
1,680,830
+43,360
+3% +$558K 0.04% 601
2019
Q1
$20.3M Buy
+1,637,470
New +$18.3M 0.05% 566

Other funds holding EPZM